Serina Therapeutics, Inc. (SER) income statement
SERNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.20−0.15 (-11.11%)
Close on Nov 19, 2026Market cap $30.48MP/E –Yield –
Serina Therapeutics, Inc. financial ratios
See a number that looks wrong?